Citigroup Portfolio holdings
Citigroup Inc., formed in 1998 through the landmark merger of Citicorp and Travelers Group, with roots tracing back to the 1812 founding of City Bank of New York, is a global financial powerhouse headquartered in New York City, managing trillions in assets. Operating in over 160 countries, Citigroup offers a broad spectrum of services, including consumer banking (via Citibank), investment banking, wealth management, and trading, serving millions of retail customers and major corporations, governments, and institutions worldwide. Under CEO Jane Fraser since 2021—the first woman to lead a major U.S. bank—Citigroup has focused on streamlining operations, exiting consumer banking in 13 markets to bolster its institutional and wealth management focus, while navigating post-2008 regulatory scrutiny and fines. Known for its vast global footprint and resilience through crises, Citigroup remains a key player in international finance, blending retail accessibility with high-stakes capital markets expertise.
Top Buys
| 1 |
Lowe's Companies
LOW
|
+$520M |
| 2 |
Industrial Select Sector SPDR Fund
XLI
|
+$329M |
| 3 |
iShares Core S&P Mid-Cap ETF
IJH
|
+$328M |
| 4 |
Invesco QQQ Trust
QQQ
|
+$283M |
| 5 |
iShares Core S&P 500 ETF
IVV
|
+$269M |
Top Sells
| 1 |
SPDR S&P 500 ETF Trust
SPY
|
+$2.08B |
| 2 |
iShares MSCI Emerging Markets ETF
EEM
|
+$253M |
| 3 |
iShares Russell 2000 ETF
IWM
|
+$232M |
| 4 |
SPDR S&P Global Natural Resources ETF
GNR
|
+$216M |
| 5 |
VanEck Oil Services ETF
OIH
|
+$192M |
Sector Composition
| 1 | Technology | 17.62% |
| 2 | Healthcare | 10.9% |
| 3 | Financials | 9.91% |
| 4 | Consumer Discretionary | 9.06% |
| 5 | Industrials | 5.65% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1101
Pinnacle West Capital
PNW
$10.3B
| $5.2M | ﹤0.01% |
80,526
-35,229
| -30% | -$2.27M |
|
1102
Hexcel
HXL
$4.92B
| $5.19M | ﹤0.01% |
100,241
-17,516
| -15% | -$906K |
|
1103
AGNC Investment
AGNC
$10.5B
| $5.17M | ﹤0.01% |
613,627
+152,776
| +33% | +$1.29M |
|
1104
Kohl's
KSS
$1.93B
| $5.16M | ﹤0.01% |
205,068
+42,864
| +26% | +$1.08M |
|
|
BFAC
1105
DELISTED
Battery Future Acquisition Corp.
BFAC
| $5.16M | ﹤0.01% |
511,062
+361,061
| +241% | +$3.64M |
|
|
RXDX
1106
DELISTED
Prometheus Biosciences, Inc. Common Stock
RXDX
| $5.16M | ﹤0.01% |
87,365
+84,584
| +3,041% | +$4.99M |
|
1107
Kosmos Energy
KOS
$808M
| $5.14M | ﹤0.01% |
994,744
+291,637
| +41% | +$1.51M |
|
1108
CGI
GIB
$20.6B
| $5.14M | ﹤0.01% |
67,896
-9,172
| -12% | -$694K |
|
1109
Fate Therapeutics
FATE
$111M
| $5.13M | ﹤0.01% |
228,896
+25,726
| +13% | +$577K |
|
1110
Westlake Corp
WLK
$10.7B
| $5.13M | ﹤0.01% |
59,037
-2,891
| -5% | -$251K |
|
1111
JPMorgan Ultra-Short Income ETF
JPST
$34B
| $5.1M | ﹤0.01% |
101,762
+19,359
| +23% | +$971K |
|
1112
EastGroup Properties
EGP
$8.85B
| $5.1M | ﹤0.01% |
35,336
+2,152
| +6% | +$311K |
|
1113
iShares MSCI Emerging Markets ex China ETF
EMXC
$13.3B
| $5.08M | ﹤0.01% |
114,764
-28,669
| -20% | -$1.27M |
|
1114
Vital Energy
VTLE
$608M
| $5.05M | ﹤0.01% |
80,359
+35,027
| +77% | +$2.2M |
|
|
PING
1115
DELISTED
Ping Identity Holding Corp.
PING
| $5.05M | ﹤0.01% |
179,852
+112,668
| +168% | +$3.16M |
|
1116
Omega Healthcare
OHI
$12.3B
| $5.02M | ﹤0.01% |
170,211
+22,237
| +15% | +$656K |
|
1117
Xtrackers MSCI EAFE Hedged Equity ETF
DBEF
$8.02B
| $5.02M | ﹤0.01% |
149,880
+11,379
| +8% | +$381K |
|
|
VMGA
1118
DELISTED
VMG Consumer Acquisition Corp. Class A Common Stock
VMGA
| $5.02M | ﹤0.01% |
500,101
+350,000
| +233% | +$3.51M |
|
|
PRLH
1119
DELISTED
Pearl Holdings Acquisition Corp Class A Ordinary Shares
PRLH
| $5.01M | ﹤0.01% |
500,401
+400,400
| +400% | +$4.01M |
|
1120
Antero Resources
AR
$9.79B
| $5.01M | ﹤0.01% |
164,201
-797,696
| -83% | -$24.4M |
|
1121
Tapestry
TPR
$23.8B
| $4.98M | ﹤0.01% |
175,009
-7,510
| -4% | -$213K |
|
1122
H&R Block
HRB
$6.73B
| $4.97M | ﹤0.01% |
116,910
-94,096
| -45% | -$4M |
|
1123
Global X Robotics & Artificial Intelligence ETF
BOTZ
$2.99B
| $4.96M | ﹤0.01% |
274,176
+17,317
| +7% | +$313K |
|
1124
Royalty Pharma
RPRX
$15.7B
| $4.95M | ﹤0.01% |
123,283
+8,893
| +8% | +$357K |
|
1125
Allogene Therapeutics
ALLO
$257M
| $4.94M | ﹤0.01% |
457,789
+216,824
| +90% | +$2.34M |
|